Abstract: The third sentence should be ‘Calculation of the initial slope was similar in a single subject, examined twice, 4 months apart (test–retest 8%).’
Methods, ‘Patients’ section: The second line should be ‘A total of 24 MRI/MRS studies were performed on five subjects of whom one had AD, two had mild cognitive impairment (MCI) and two were healthy older adults with mean age of 78 ± 3 years, and two were females. The AD subject was examined twice.’
Methods, ‘Neuroimaging and Spectroscopy’ section: The following sentence should be added to the end, ‘Test–retest of 13C MRS in an AD was performed at 4 months with reproducibility of 8%.’
Table 1 has been revised, as shown below.
Table 1.
Compilations of subjects’ characteristics, proton, carbon MRS, and neuropsychological assessment results
| Patient 1 control | Patient 2 control | Patient 3 MCI | Patient 4 MCI | Patient 5A* AD | Patient 5B* AD | |
|---|---|---|---|---|---|---|
| Subject characteristics | ||||||
| Age | 80 | 83 | 77 | 81 | 76 | |
| Gender | M | M | M | M | F | |
| MMSE | 30 | 28 | 26 | 27 | 22 | |
| Proton MRS results | ||||||
| NAA/Cr | 1.45 | 1.37 | 1.47 | 1.37 | 1.62 | 1.39 |
| mi/Cr | 0.56 | 0.72 | 0.77 | 0.74 | 0.85 | 0.83 |
| NAA/mi | 2.6 | 1.92 | 1.92 | 1.85 | 1.34 | 1.67 |
| Carbon MRS results | ||||||
| Rate of bicarbonate production (% FE/minute) | 0.023 | 0.03 | 0.042 | 0.033 | 0.056 | 0.06 |
| Neuropsychological assessment (Z scores) | ||||||
| Attention/concentration Working memory | WNL | WNL | −2 | WNL | −1.6 | −1.6 |
| Psychomotor/Information processing | WNL | WNL | WNL | WNL | −1.5 | −1.5 |
| Language functions | WNL | WNL | −1.5 | WNL | −1.5 | −1.5 |
| Verbal memory | WNL | WNL | −1.3 | −1.3 | −3 | −3 |
| Nonverbal memory | WNL | WNL | −3 | WNL | −3 | −3 |
| Visuospatial/construction | WNL | −1.4 | −1.4 | −2 | −2 | −2 |
| Executive functions | WNL | −1.4 | −2.5 | WNL | −3 | −3 |
| Motor functions | WNL | WNL | −1.3 | WNL | WNL | WNL |
Notes: The AD subject was examined twice with a 4-month interval between studies.
Abbreviations: AD, Alzheimer’s disease; Cr, creatine; FE, fractional enrichment; mi, myoinositol; MCI, mild cognitive impairment; MMSE, mini-mental state examination; MRS, magnetic resonance spectroscopy; NAA, N-acetyl aspartate; WNL, within normal limits.
